Lu-177-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney

Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Christiane Schuchardt, Karin Niepsch, Thomas Langbein, Richard P. Baum*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1579-1586
Number of pages8
JournalJournal of Nuclear Medicine
Volume60
Issue number11
DOIs
Publication statusPublished - 1 Nov 2019

Keywords

  • prostate-specific membrane antigen
  • radioligand therapy
  • single functioning kidney
  • Lu-177
  • renal toxicity
  • TARGETED RADIONUCLIDE THERAPY
  • PSMA INHIBITOR
  • LIGANDS
  • EXPRESSION
  • CRITERIA
  • RECIST
  • SAMPLE
  • TUMORS

Cite this

Zhang, Jingjing ; Kulkarni, Harshad R. ; Singh, Aviral ; Schuchardt, Christiane ; Niepsch, Karin ; Langbein, Thomas ; Baum, Richard P. / Lu-177-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney. In: Journal of Nuclear Medicine. 2019 ; Vol. 60, No. 11. pp. 1579-1586.
@article{a10c793db49d4a59a20bbecd0e6164e4,
title = "Lu-177-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney",
keywords = "prostate-specific membrane antigen, radioligand therapy, single functioning kidney, Lu-177, renal toxicity, TARGETED RADIONUCLIDE THERAPY, PSMA INHIBITOR, LIGANDS, EXPRESSION, CRITERIA, RECIST, SAMPLE, TUMORS",
author = "Jingjing Zhang and Kulkarni, {Harshad R.} and Aviral Singh and Christiane Schuchardt and Karin Niepsch and Thomas Langbein and Baum, {Richard P.}",
year = "2019",
month = "11",
day = "1",
doi = "10.2967/jnumed.118.223149",
language = "English",
volume = "60",
pages = "1579--1586",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine and Molecular Imaging",
number = "11",

}

Lu-177-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney. / Zhang, Jingjing; Kulkarni, Harshad R.; Singh, Aviral; Schuchardt, Christiane; Niepsch, Karin; Langbein, Thomas; Baum, Richard P.

In: Journal of Nuclear Medicine, Vol. 60, No. 11, 01.11.2019, p. 1579-1586.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Lu-177-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney

AU - Zhang, Jingjing

AU - Kulkarni, Harshad R.

AU - Singh, Aviral

AU - Schuchardt, Christiane

AU - Niepsch, Karin

AU - Langbein, Thomas

AU - Baum, Richard P.

PY - 2019/11/1

Y1 - 2019/11/1

KW - prostate-specific membrane antigen

KW - radioligand therapy

KW - single functioning kidney

KW - Lu-177

KW - renal toxicity

KW - TARGETED RADIONUCLIDE THERAPY

KW - PSMA INHIBITOR

KW - LIGANDS

KW - EXPRESSION

KW - CRITERIA

KW - RECIST

KW - SAMPLE

KW - TUMORS

U2 - 10.2967/jnumed.118.223149

DO - 10.2967/jnumed.118.223149

M3 - Article

VL - 60

SP - 1579

EP - 1586

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 11

ER -